Profile
ABIO NVO VRTX REGN SGEN ARGX
Company Name ARCA biopharma, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $34.82M $473.53B $116.14B $79.76B $43.15B $36.58B
Employees 0.00K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Thomas A. Keuer Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABIO NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ABIO NVO VRTX REGN SGEN ARGX
Last Close $28.8 $105.06 $450.97 $738 $228.74 $605.92
High 52 $28.8 $146.91 $516.74 $1201.76 $228.74 $605.92
Low 52 $1.58 $101.74 $392.81 $738 $228.74 $356.01
Price vs. 52 Week High 0 % -28.49 % -12.73 % -38.59 % 0 % 0 %
Price vs. 52 Week Low 1722.78 % 3.26 % 14.81 % 0 % 0 % 70.2 %
Total Return
ABIO NVO VRTX REGN SGEN ARGX
1 Month Return 0 % -9.23 % -4.06 % -21.61 % 0 % 8.6 %
3 Month Return 592.31 % -23.3 % -6.29 % -38.45 % 0 % 17.27 %
6 Month Return 783.44 % -22.5 % 0.04 % -24.74 % 0 % 67.84 %
9 Month Return 1666.87 % -14.9 % 4.85 % -24.79 % 0 % 47.96 %
YTD Return 1594.12 % 1.56 % 10.83 % -15.97 % 0 % 59.27 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABIO NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) 72.73 % 1.32 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) 20.95 % 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ABIO NVO VRTX REGN SGEN ARGX
Asset Growth -12.12 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 2.63 % 32.32 % 9.25 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 91.84 % 2074.24 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 215.48 % 3040.37 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 494.04 % 9013.37 %
EBIT Growth 31.14 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Net Income Growth 42.32 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 82.09 % 106.79 % 34.59 % 13.48 % -764.83 % 63.97 %
Net Income 5 Yeari Growth Per Share 96.41 % 133.86 % 70.33 % 74.02 % -276.93 % -143.56 %
Net Income 10 Yeari Growth Per Share 99.63 % 98.61 % 809.6 % 871.12 % -624.16 % -857.4 %
Operating Income Growth 31.14 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) 54.05 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 78.79 % 118.29 % 9.63 % 76.95 % -148.34 % 21.62 %
Operating 5 Year CFG 96.75 % 163.51 % 174.78 % 125.17 % -195.86 % -329.48 %
Operating 10 Year CFG 99.55 % 150.92 % 6084.35 % 713.56 % -2622.09 % -1280.79 %
EPS Growth 42.19 % 52.28 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 42.19 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -11.2 % 29 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -74 % 75.22 % 104.06 % 137.56 % 33.92 % 93.95 %
Share Holder 5 Year Equity Growth Per Share -67.24 % 121.9 % 291.14 % 219.1 % 220.81 % 318.67 %
Share Holder 10 Year Equity Growth Per Share -98.87 % 49.62 % 1030.79 % 1286.9 % 691.19 % 3655.65 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth - 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 54.06 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ABIO NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 52.27 % 84.66 % 86.1 % 83.54 % 72.37 % 86.82 %
Return on Assets TTM -21.27 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -20.18 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -26.9 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 82.18 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -4977.84 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM - 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.4 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.15 1.72 3.73 4.58 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.76 0.65 0.91
Fixed Asset Turnover TTM 1466.67 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 0.52 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -0.47 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -0.47 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 229.43 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -3913.07 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM - 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -5.06 50.51 -99.79 23.61 -141.85 -173.18
Price To Operating Cash Flows Ratio TTM -60.66 28.29 -138.08 18.78 -203.89 -250.16
Price Cash Flow Ratio TTM -60.66 28.29 -138.08 18.78 -203.89 -250.16
Income Statement (TTM)
ABIO NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.01B $114.63B $4.61B $4.65B $-0.62B $-0.22B
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -0.37 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABIO NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.04B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.04B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABIO NVO VRTX REGN SGEN ARGX
Net Income $-0.01B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.3
ABCL AbCellera Biologics Inc. 2.76
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.98
ABOS Acumen Pharmaceuticals, Inc. 2.37
ABSI Absci Corporation 2.56
ABUS Arbutus Biopharma Corporation 3.51
ABVC ABVC BioPharma, Inc. 0.5488
ABVX Abivax SA American Depositary Shares 8.78
ACAD ACADIA Pharmaceuticals Inc. 16.37
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 0.9
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.06
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.38
ACLX Arcellx, Inc. 90.44
ACRV Acrivon Therapeutics, Inc. Common Stock 6.55
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 1.35
ETFs With Exposure to ABIO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 296.51
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 131.65
VXF Vanguard Extended Market Index Fund 0 203.42
IWC iShares Micro-Cap ETF 0.00857 135.74
DFAT Dimensional U.S. Targeted Value ETF 0.00015047 60.18
VTSAX Vanguard Total Stock Market Index Fund 0 144.38
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 154.29
VITSX Vanguard Total Stock Market Index Fund 0 144.4
DFSU Dimensional US Sustainability Core 1 ETF 0.00000116 39.07
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000237478 102.35
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 154.3
SOLR SmartETFs Sustainable Energy II ETF 2.24 26.44
DCOR Dimensional ETF Trust 0.00000603 66.53
VEMPX Vanguard Extended Market Index InstlPlus 0 380.77
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 270.87
Unlock